Aristo Bio-Tech and Lifescience (NSE:ARISTO) ROCE %: 1.64% (As of Mar. 2025)


NSE:ARISTO Aristo Bio-Tech and Lifescience Ltd NSE:ARISTO
59 GF Score
Price ₹95.70
View Full Analysis

What is Aristo Bio-Tech and Lifescience ROCE %?

Aristo Bio-Tech and Lifescience NSE:ARISTO 59 ROCE % is 1.64% as of Mar. 2025. GuruFocus rates NSE:ARISTO with a GF Score™ of 59/100.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Aristo Bio-Tech and Lifescience's annualized ROCE % for the quarter that ended in Mar. 2025 was 1.64%.

Aristo Bio-Tech and Lifescience  (NSE:ARISTO) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Aristo Bio-Tech and Lifescience ROCE % Related Terms

Aristo Bio-Tech and Lifescience ROCE % Historical Data

* Premium members only.

The historical data trend for Aristo Bio-Tech and Lifescience's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aristo Bio-Tech and Lifescience ROCE % Chart

Aristo Bio-Tech and Lifescience Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
ROCE %
Get a 7-Day Free Trial 15.31 15.00 20.92 17.58 16.83

Aristo Bio-Tech and Lifescience Semi-Annual Data
Mar20 Mar21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
ROCE % Get a 7-Day Free Trial Premium Member Only 14.71 22.27 12.97 31.25 1.64
NSE:ARISTO
59GF Score
Aristo Bio-Tech and Lifescience Ltd NSE:ARISTO
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aristo Bio-Tech and Lifescience ROCE % Calculation

Aristo Bio-Tech and Lifescience's annualized ROCE % for the fiscal year that ended in Mar. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2025 )  (A: Mar. 2024 )(A: Mar. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2025 )  (A: Mar. 2024 )(A: Mar. 2025 )
=74.677/( ( (1272.87 - 835.681) + (1406.239 - 955.757) )/ 2 )
=74.677/( (437.189+450.482)/ 2 )
=74.677/443.8355
=16.83 %

Aristo Bio-Tech and Lifescience's ROCE % of for the quarter that ended in Mar. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2025 )  (Q: Sep. 2024 )(Q: Mar. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2025 )  (Q: Sep. 2024 )(Q: Mar. 2025 )
=7.57/( ( (2232.833 - 1762.52) + (1406.239 - 955.757) )/ 2 )
=7.57/( ( 470.313 + 450.482 )/ 2 )
=7.57/460.3975
=1.64 %

(1) Note: The EBIT data used here is two times the semi-annual (Mar. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 1.64% mean?
Aristo Bio-Tech and Lifescience (NSE:ARISTO) has a ROCE % of 1.64% as of Mar. 2025.
Is Aristo Bio-Tech and Lifescience's ROCE % too high?
Aristo Bio-Tech and Lifescience's current ROCE % is 1.64%. The Agriculture industry median ROCE % is 9.46. Aristo Bio-Tech and Lifescience's value of 1.64% is 82.7% below this industry median. Overall, Aristo Bio-Tech and Lifescience has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does Aristo Bio-Tech and Lifescience's ROCE % compare to CTVA and CF?
Aristo Bio-Tech and Lifescience's ROCE % of 1.64% can be compared against companies in the Agriculture industry. The industry median ROCE % is 9.46. Aristo Bio-Tech and Lifescience's value of 1.64% is 82.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for an Agriculture company?
The median ROCE % among Agriculture companies is 9.46, based on 254 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aristo Bio-Tech and Lifescience's current ROCE % of 1.64% is 82.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Agriculture industry, the median ROCE % is 9.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aristo Bio-Tech and Lifescience's current ROCE % is 1.64%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aristo Bio-Tech and Lifescience stock overvalued right now?
Aristo Bio-Tech and Lifescience (NSE:ARISTO) has a current ROCE % of 1.64%. The current ROCE % is 1.64% and 82.7% below the Agriculture industry median of 9.46. Aristo Bio-Tech and Lifescience's overall GF Score™ is 59/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Aristo Bio-Tech and Lifescience (NSE:ARISTO), the current ROCE % is 1.64% as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aristo Bio-Tech and Lifescience Business Description

Address E-24, 25, 26, G.I.D.C, Manjusar, Taluka Savli, Vadodara, GJ, IND, 391775
Aristo Bio-Tech and Lifescience Ltd is an agrochemical company. It is mainly engaged in the manufacturing, formulation, supplying, packaging and job work services of various pesticides. The company exports products like Insecticides, Herbicides, Fungicides, Plant Growth Regulators and a wide variety of other Agrochemicals.
59GF Score

Get the complete analysis for NSE:ARISTO

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹95.70
Price